Cargando…

Tolerating Factor VIII: Recent Progress

Development of neutralizing antibodies against biotherapeutic agents administered to prevent or treat various clinical conditions is a longstanding and growing problem faced by patients, medical providers and pharmaceutical companies. The hemophilia A community has deep experience with attempting to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacroix-Desmazes, Sebastien, Voorberg, Jan, Lillicrap, David, Scott, David W., Pratt, Kathleen P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965068/ https://www.ncbi.nlm.nih.gov/pubmed/31998296 http://dx.doi.org/10.3389/fimmu.2019.02991

Ejemplares similares

Editorial: Tolerating Factor VIII: Novel Strategies to Prevent and Reverse Neutralizing Anti-FVIII Antibodies
por: Lacroix-Desmazes, Sébastien, et al.
Publicado: (2021)

Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies
por: Scott, David W., et al.
Publicado: (2020)

Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
por: Varthaman, Aditi, et al.
Publicado: (2019)

Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A
por: Delignat, Sandrine, et al.
Publicado: (2019)

Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy
por: Meeks, Shannon L., et al.
Publicado: (2020)

Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2020)

Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
por: Georgescu, Maria T., et al.
Publicado: (2020)

Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
por: Sherman, Alexandra, et al.
Publicado: (2017)

Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance
por: Mimoun, Angelina, et al.
Publicado: (2020)

To clear or to fear: An innate perspective on factor VIII immunity
por: Lai, Jesse Derek, et al.
Publicado: (2016)

Complement C3 is a novel modulator of the anti-factor VIII immune response
por: Rayes, Julie, et al.
Publicado: (2018)

Factor VIII antibody immune complexes modulate the humoral response to factor VIII in an epitope-dependent manner
por: Batsuli, Glaivy, et al.
Publicado: (2023)

Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms
por: Georgescu, Maria T., et al.
Publicado: (2018)

Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2020)

Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking
por: Ebberink, Eduard H.T.M., et al.
Publicado: (2017)

Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
por: Krishnamoorthy, Sriram, et al.
Publicado: (2015)

A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy
por: Chen, Alex C., et al.
Publicado: (2020)

Storage of Factor VIII Variants with Impaired von Willebrand Factor Binding in Weibel-Palade Bodies in Endothelial Cells
por: van den Biggelaar, Maartje, et al.
Publicado: (2011)

Japanese Encephalitis Virus Infected Human Monocyte-Derived Dendritic Cells Activate a Transcriptional Network Leading to an Antiviral Inflammatory Response
por: Chauhan, Shailendra, et al.
Publicado: (2021)

N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice
por: Lai, Jesse D., et al.
Publicado: (2018)

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A
por: Bachelet, Delphine, et al.
Publicado: (2019)

A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A
por: Tatsumi, Kohei, et al.
Publicado: (2013)

Removal of Mannose-Ending Glycan at Asn(2118) Abrogates FVIII Presentation by Human Monocyte-Derived Dendritic Cells
por: Delignat, Sandrine, et al.
Publicado: (2020)

Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway
por: Patel, Seema R., et al.
Publicado: (2022)

Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII
por: van Haren, Simon D., et al.
Publicado: (2013)

The Immune Response to the fVIII Gene Therapy in Preclinical Models
por: Patel, Seema R., et al.
Publicado: (2020)

Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature
por: Sanges, Sébastien, et al.
Publicado: (2020)

Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16
por: Lagassé, H.A. Daniel, et al.
Publicado: (2021)

Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor
por: Ronayne, Estelle K., et al.
Publicado: (2021)

Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation
por: Zerra, Patricia E., et al.
Publicado: (2020)

Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
por: Du, Xiaoxiao, et al.
Publicado: (2020)

Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells
por: Peyron, Ivan, et al.
Publicado: (2018)

Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura
por: Laghmouchi, Aicha, et al.
Publicado: (2021)

Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease
por: Lelas, Antonela, et al.
Publicado: (2021)

Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis
por: Oomen, Ilja, et al.
Publicado: (2022)

Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance
por: Scott, David W.
Publicado: (2021)

Factor VIII companion diagnostic for haemophilia
por: Hu, Chunxiao, et al.
Publicado: (2022)

Recent progress in pneumococcal protein vaccines
por: Li, Sha, et al.
Publicado: (2023)

Recent Advances in Costimulatory Blockade to Induce Immune Tolerance in Liver Transplantation
por: Ding, Mingjie, et al.
Publicado: (2021)

From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance
por: Scott, David W.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kefb88bo8p6c4ai1gpsu85c2vh